Erytech Pharma S.A. buy tbackenh
Start price
26.09.16
/
50%
€19.25
Target price
27.03.17
€22.00
Performance (%)
-25.71%
End price
27.03.17
€14.30
Summary
This prediction ended on 27.03.17 with a price of €14.30. The prediction for Erytech Pharma S.A. disappointed with a performance of -25.71%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | -0.821% | -2.027% | 9.725% | 57.409% |
| iShares Nasdaq 100 | -1.743% | -5.354% | -0.863% | 80.459% |
| iShares Nikkei 225® | 1.215% | 6.383% | 27.786% | 62.930% |
| iShares S&P 500 | -1.167% | -3.462% | 0.098% | 55.836% |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€28.20
31.03.17
31.03.17
€32.00
02.10.17
02.10.17
-17.59%
02.10.17
02.10.17
